Clonal structure and 21-year evolution of Streptococcus pneumoniae serotype 1 isolates in northern Spain

Clinical Microbiology and Infection

Volumn 15, Issue 9, 2009, Pages 875-877

  Marimon, J M ^a,b   Ercibengoa, M ^b   Alonso, M ^a,b   Zubizarreta, M ^a   Perez Trallero E ^a,b  

^a HOSPITAL DONOSTIA   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Lineages; MLST; PCV7; Pneumococcal conjugate vaccine; Pneumococcal infection

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; RIFAMPICIN; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CELL LINEAGE; CLONAL SPECIES; EVOLUTION; GENETIC HETEROGENEITY; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

STREPTOCOCCUS PNEUMONIAE;

EID: 69249085390     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02883.x     Document Type: Article

References (15)

1. Brueggemann AB, Spratt BG. Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. J Clin Microbiol 2003; 41: 4966-4970.
2. Leimkugel J, Adams Forgor A, Gagneux S et al. An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis 2005; 192: 192-199.
3. Whitney CG, Farley MM, Hadler J et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348: 1737-1746.
4. Farrell DJ, Klugman KP, Pichichero M. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis J 2007; 26: 123-128.
5. Singleton RJ, Hennessy TW, Bulkow LR et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007; 297: 1784-1792.
6. Mintegi S, Benito J, González M, Astobiza E, Sanchez J, Santiago M. Impact of the pneumococcal conjugate vaccine in the management of highly febrile children aged 6 to 24months in an emergency department. Pediatr Emerg Care 2006; 22: 566-569.
7. Marimon JM, Iglesias L, Vicente D et al. Molecular characterization of erythromycin-resistant clinical isolates of the four major antimicrobial-resistant Spanish clones of Streptococcus pneumoniae (Spain 23F-1, Spain 6B-2, Spain 9V-3 and Spain 14-5). Microb Drug Resist 2003; 9: 133-137.
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 17th informational supplement. M100-S17. Wayne, PA: CLSI, 2007.
9. Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: Identification of clones associated with serious invasive disease. Microbiology 1998; 144: 3049-3060.
10. Dias R, Caniça M. Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine. FEMS Immunol Med Microbiol 2007; 51: 35-42.
11. Muñoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia JJ, Pallares R. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 2008; 46: 174-182.
12. Nunes S, Sá-Leão R, Pereira LC, Lencastre H. Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era. Clin Microbiol Infect 2008; 14: 82-84.
13. Obando I, Arroyo LA, Sánchez-Tatay D et al. Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine. Clin Microbiol Infect 2007; 13: 347-348.
14. McChlery SM, Scott KJ, Clarke SC. Clonal analysis of invasive pneumococcal isolates in Scotland and coverage of serotypes by the licensed conjugate polysaccharide pneumococcal vaccine: Possible implications for UK vaccine policy. Eur J Clin Microbiol Infect Dis 2005; 24: 262-267.
15. Serrano I, Melo-Cristino J, Carriço JA, Ramirez M. Characterization of the genetic lineages responsible for pneumococcal invasive disease in Portugal. J Clin Microbiol 2005; 43: 1706-1715.